Stepan (SCL)
(Delayed Data from NYSE)
$79.24 USD
-1.84 (-2.27%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $79.41 +0.17 (0.21%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$79.24 USD
-1.84 (-2.27%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $79.41 +0.17 (0.21%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth C Momentum A VGM
Zacks News
Stepan Company (SCL) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Stepan Company (SCL) has been struggling lately, but the selling pressure may be coming to an end soon
Dow Inc. (DOW) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Dow Inc. (DOW) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Stepan Co. (SCL) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Stepan Co. (SCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Huntsman (HUN) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Huntsman (HUN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Stepan Co. (SCL) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 27.27% and 5.84%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Stepan Company (SCL) Ahead of Earnings?
by Zacks Equity Research
Stepan Company (SCL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Stepan Co. (SCL) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 31.48% and 8.45%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Stepan Company (SCL) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Stepan Company (SCL) has been struggling lately, but the selling pressure may be coming to an end soon.
Stepan Co. (SCL) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 11.43% and 1.93%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Stepan (SCL) This Earnings Season?
by Zacks Equity Research
Stepan (SCL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Stepan Co. (SCL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Chemical Stocks to Snap Up on Global Manufacturing Revival
by Anindya Barman
With China seeing an economic rebound and manufacturing activities are improving around the world, things are looking up for the chemical industry.
Stepan Co. (SCL) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Stepan Co. (SCL) could produce exceptional returns because of its solid growth attributes.
Coronavirus Clouds Diversified Chemical Industry Outlook
by Anindya Barman
Diversified chemicals companies are buffeted by a downturn in demand across major markets and raw material cost pressure due to coronavirus.
Stepan Co. (SCL) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Stepan Co. (SCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Moving Average Crossover Alert: Stepan Company
by Zacks Equity Research
Stepan Company is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Stepan Co. (SCL) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 39.83% and 5.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Stepan Co. (SCL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemical Industry Eyes Recovery From Coronavirus Crisis: 5 Picks
by Anindya Barman
A recovery in China coupled with the gradual reopening of major economies globally is expected to usher in a better second half for chemical companies.
Global Chemical April Output Dips Under Weight of Coronavirus
by Anindya Barman
Global chemical production dropped 1.3% in April on declines across all regions amid the coronavirus pandemic.
Stepan Co. (SCL) Q1 Earnings Top Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 31.65% and -0.56%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Stepan Co. (SCL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stepan Co. (SCL) Tops Q3 Earnings Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 7.14% and -8.84%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Stepan Co. (SCL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Stepan Co. (SCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stepan Co. (SCL) Tops Q2 Earnings Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 14.50% and -8.84%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?